Kainos Medicine, Inc. (KOSDAQ:284620)

South Korea · Delayed Price · Currency is KRW

1,087.00

-105.00 (-8.81%)

At close: Aug 14, 2025

Kainos Medicine Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,173	1,172	590.37	267.31	130.02	1,662
Revenue Growth	42.98%	98.46%	120.85%	105.59%	-92.18%	-
Gross Profit	163.47	170.35	390.48	176.6	61.91	1,624
Operating Income	-6,186	-6,864	-12,503	-16,812	-16,156	-11,219
Net Income	-6,925	-7,785	-12,190	-15,235	-15,881	-16,212
Earnings Per Share	-211.89	-246.07	-438.00	-546.00	-666.22	-765.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,819	2,866	3,834	16,417	29,952	34,231
Total Debt	107.92	147.28	491.29	400.83	3,912	14,372
Net Cash (Debt)	1,711	2,719	3,343	16,016	26,040	19,859
Net Cash Growth	-71.74%	-18.66%	-79.13%	-38.50%	31.12%	7.24%
Net Cash Per Share	52.34	85.95	120.11	573.59	1092.41	937.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-3,808	-5,917	-9,709	-14,221	-11,296	-9,195
Capital Expenditures	-5.52	-5.52	-0.08	-3,998	-1,826	-1,939
Free Cash Flow	-3,813	-5,922	-9,709	-18,220	-13,122	-11,134
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	13.94%	14.54%	66.14%	66.06%	47.62%	97.68%
Operating Margin	-527.31%	-585.84%	-2117.82%	-6289.14%	-12425.09%	-674.87%
Pretax Margin	-590.15%	-664.23%	-2064.66%	-5700.53%	-12238.40%	-975.95%
Profit Margin	-590.35%	-664.43%	-2064.85%	-5699.35%	-12213.85%	-975.17%
FCF Margin	-325.06%	-505.48%	-1644.59%	-6815.87%	-10092.16%	-669.76%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	30.31	30.35	151.32	451.25	880.46	168.40